Dencare (001328.SZ) indirect controlling shareholders concerted action party intends to reduce its holdings by no more than 1.74%.
Dengkang Oral (001328.SZ) announced that Chongqing Yufu Holding Group Co., Ltd. (hereinafter referred to as "Yufu Group"), an indirect controlling shareholder, plans to reduce its holdings through Chongqing Zhongbai Technology Group Co., Ltd. (hereinafter referred to as "Zhongbai Group"), a person acting in concert, by no more than 2.9877 million shares (accounting for 1.74% of the company's total share capital) within three months from the 15th trading day after the announcement date (i.e., from October 8, 2026, to January 7, 2027) through centralized bidding and block trading.
Dencare (001328.SZ) announced that its indirect controlling shareholder, Chongqing Yufu Holding Group Co., Ltd. (hereinafter referred to as "Yufu Group"), along with its concerted action party, Chongqing Chongbai Technology Group Co., Ltd. (hereinafter referred to as "Chongqing Chongbai Technology Group"), plans to reduce its holdings by no more than 2,987,700 shares (accounting for 1.74% of the company's total share capital) through centralized bidding and block trading within three months from fifteen trading days after the disclosure of this announcement (i.e., from October 8, 2026, to January 7, 2027).
Related Articles
BIOHEART-B(02185) has appointed GIORGIO GOBBI as Vice President of Global Therapeutic Development at Antong.
POLY XVERSE IT (00209): Zhao Kai resigns as Chairman and Executive Director
HOMELAND ITL (03798) repurchased 10,000 shares for HKD 12,000 on September 7.
BIOHEART-B(02185) has appointed GIORGIO GOBBI as Vice President of Global Therapeutic Development at Antong.
POLY XVERSE IT (00209): Zhao Kai resigns as Chairman and Executive Director
HOMELAND ITL (03798) repurchased 10,000 shares for HKD 12,000 on September 7.
RECOMMEND
